COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status
Tiffany Thomas(Columbia University), Angelo D’Alessandro(University of Colorado Anschutz Medical Campus), James C. Zimring(University of Washington), Travis Nemkov(Touch of Life Technologies (United States)), Steven L. Spitalnik(Columbia University), Lorenzo Bertolone(University of Colorado Anschutz Medical Campus), Kirk C. Hansen(University of Colorado Denver), Davide Stefanoni(University of Colorado Anschutz Medical Campus), Eldad A. Hod(Presbyterian Hospital), Krystalyn E. Hudson(Columbia University), Richard O. Francis(Presbyterian Hospital), Julie A. Reisz(University of Colorado Anschutz Medical Campus)
Cited by 600
Related Papers
Deployment of convalescent plasma for the prevention and treatment of COVID-19
|Journal of Clinical Investigation|2020|863
Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells
|Cancer Cell|2018|565
OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation
|Proceedings of the National Academy of Sciences|2018|556
Monocytic Subclones Confer Resistance to Venetoclax-Based Therapy in Patients with Acute Myeloid Leukemia
|Cancer Discovery|2020|550
Effects of Red-Cell Storage Duration on Patients Undergoing Cardiac Surgery
|New England Journal of Medicine|2015|486